This group we only share news 🗞️ updates, we don’t offer any buying or Selling services, please consult your Financial Advisor before taking any Investment Decision Based on News
We are not SEBI registered,
Contact: Daytradertelugu@gmail.com
KOLTE PATIL DEVELOPERS: Q4 EBITDA RUPEES 1.73B VS 405M (YOY) || Q4 EBITDA MARGIN 21.76% VS 10.76% (YOY)

BIG BEAT EBITDA AND MARGINS
IEX: Q4 EBITDA RUPEES 931M VS 949M (YOY)
TTK PRESTIGE: Q4 EBITDA RUPEES 802M VS 1.09B (YOY) || Q4 EBITDA MARGIN 13.14% VS 15.65% (YOY)

POOR EBITDA AND MARGINS
DHANUKA AGRITECH: Q4 EBITDA RUPEES 779M VS 652M (YOY) || Q4 EBITDA MARGIN 21% VS 20.48% (YOY)
LINCOLN PHARMA: Q4 EBITDA RUPEES 166M VS 174M (YOY) || Q4 EBITDA MARGIN 14.76% VS 17.00% (YOY)
Back to Top